Clinicians from Children’s Hospital of Philadelphia Present Lectures in Western Canada on Cutting-edge Treatment Options for Children

Published on in International Update CHOP News

Clinicians from Children’s Hospital of Philadelphia will be presenting lectures at Canadian hospitals and universities on cutting-edge lymphatic treatments, and proton therapy and T cell therapy for targeted treatment in pediatric cancer.

Yoav Dori, MD, PhD, is a Pediatric Cardiologist and the Director of Pediatric Lymphatic Imaging and Interventions and Lymphatic Research at Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania. Dr. Dori delivered two lectures in Western Canada on “Lymphatic Circulation in Health and Disease: New Discoveries and New Treatment Options," on Sept. 19 he presented at Royal University Hospital in Saskatoon; and on Sept. 20 at Stollery Children’s Hospital in Edmonton. 

The Center for Lymphatic Imaging and Interventions at Children’s Hospital of Philadelphia provides highly specialized care for children with lymphatic leaks and lymphatic flow disorders. Experts in the center are developing advanced imaging and interventional technologies to map the anatomy and flow of the lymphatic system. This allows the team to more accurately identify and manage several chronic and debilitating conditions, using a variety of minimally invasive treatment options. The clinicians on the team have treated more than 500 adults and 100 children with lymphatic flow disorders, making the program the largest and most active of its kind in the world.

Robert Lustig, MD, is the Director of the Network Development Program, Attending Physician at Children’s Hospital of Philadelphia and Professor of Clinical Radiation Oncology in the Perelman School of Medicine at the University of Pennsylvania. He cares for patients in Penn’s Roberts Proton Therapy Center. Dr. Lustig will travel to Montreal on Sept. 22, 2016, to deliver a lecture on “Proton Therapy for Pediatric Malignancies” at CHU-Sainte Justine.

Stephan A. Grupp, MD, PhD, is the Director of the Cancer Immunotherapy Program, Director of Translational Research for the Center for Childhood Cancer Research at CHOP and Attending Physician in the Cancer Center at CHOP. Dr. Grupp visited Children’s Hospital of Eastern Ontario on Oct. 4 to deliver a lecture called “CAR-T Revolution in Leukemia” about T cell therapy for pediatric leukemia.  

Contact: Joey McCool Ryan, The Children’s Hospital of Philadelphia, 267-426-6070 or mccool@email.chop.edu